# Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

> **NCT00447460** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Salamanca** · enrollment: 15 (—)

## Conditions studied

- Graft-vs-Host Disease (GVHD)

## Interventions

- **PROCEDURE:** Mesenchymal stem cell (MSC)

## Key facts

- **NCT ID:** NCT00447460
- **Lead sponsor:** University of Salamanca
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2009-08
- **Target enrollment:** 15 (—)
- **Last updated:** 2007-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447460, "Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell". Retrieved via MORVS 2026-10-26 from https://api.morvs.ai/clinical/NCT00447460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*